Envestnet Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $146M | Buy |
3,959,430
+1,185,996
| +43% | +$56.2M | 0.04% | 413 |
|
|
2025
Q4 | $141M | Sell |
2,773,434
-1,150,167
| -29% | -$58.8M | 0.04% | 397 |
|
|
2025
Q3 | $218M | Sell |
3,923,601
-262,089
| -6% | -$15.3M | 0.06% | 288 |
|
|
2025
Q2 | $289M | Sell |
4,185,690
-305,824
| -7% | -$20.8M | 0.08% | 217 |
|
|
2025
Q1 | $312M | Buy |
4,491,514
+323,831
| +8% | +$26.7M | 0.1% | 186 |
|
|
2024
Q4 | $359M | Sell |
4,167,683
-110,977
| -3% | -$12M | 0.12% | 157 |
|
|
2024
Q3 | $509M | Buy |
4,278,660
+24,480
| +0.6% | +$3.26M | 0.16% | 108 |
|
|
2024
Q2 | $607M | Buy |
4,254,180
+58,935
| +1% | +$7.81M | 0.21% | 86 |
|
|
2024
Q1 | $539M | Sell |
4,195,245
-18,733
| -0.4% | -$2.23M | 0.2% | 86 |
|
|
2023
Q4 | $436M | Sell |
4,213,978
-338,503
| -7% | -$33.5M | 0.18% | 107 |
|
|
2023
Q3 | $414M | Buy |
4,552,481
+1,007,251
| +28% | +$88.7M | 0.19% | 101 |
|
|
2023
Q2 | $287M | Sell |
3,545,230
-7,072,502
| -67% | -$578M | 0.13% | 135 |
|
|
2023
Q1 | $271M | Buy |
10,617,732
+7,074,496
| +200% | +$502M | 0.13% | 131 |
|
|
2022
Q4 | $240M | Sell |
3,543,236
-65,696
| -2% | -$3.85M | 0.12% | 151 |
|
|
2022
Q3 | $180M | Sell |
3,608,932
-6,330
| -0.2% | -$339K | 0.1% | 181 |
|
|
2022
Q2 | $201M | Buy |
3,615,262
+407,996
| +13% | +$22.6M | 0.11% | 169 |
|
|
2022
Q1 | $178M | Buy |
3,207,266
+372,244
| +13% | +$19.1M | 0.09% | 201 |
|
|
2021
Q4 | $159M | Buy |
2,835,022
+151,076
| +6% | +$8.18M | 0.08% | 226 |
|
|
2021
Q3 | $129M | Buy |
2,683,946
+84,280
| +3% | +$4.07M | 0.07% | 235 |
|
|
2021
Q2 | $109M | Buy |
2,599,666
+101,754
| +4% | +$3.94M | 0.06% | 253 |
|
|
2021
Q1 | $84.2M | Buy |
2,497,912
+153,532
| +7% | +$5.47M | 0.05% | 282 |
|
|
2020
Q4 | $81.9M | Buy |
2,344,380
+30,556
| +1% | +$1.06M | 0.06% | 238 |
|
|
2020
Q3 | $80.3M | Sell |
2,313,824
-17,250
| -0.7% | -$575K | 0.07% | 213 |
|
|
2020
Q2 | $76.3M | Buy |
2,331,074
+77,512
| +3% | +$2.47M | 0.07% | 212 |
|
|
2020
Q1 | $67.8M | Buy |
2,253,562
+150,230
| +7% | +$4.47M | 0.08% | 191 |
|
|
2019
Q4 | $60.9M | Buy |
2,103,332
+53,444
| +3% | +$1.48M | 0.06% | 235 |
|
|
2019
Q3 | $53M | Buy |
2,049,888
+79,220
| +4% | +$2M | 0.06% | 252 |
|
|
2019
Q2 | $50.3M | Buy |
1,970,668
+45,900
| +2% | +$1.13M | 0.06% | 229 |
|
|
2019
Q1 | $50.3M | Sell |
1,924,768
-59,782
| -3% | -$1.47M | 0.07% | 209 |
|
|
2018
Q4 | $45.7M | Buy |
1,984,550
+815,682
| +70% | +$18.1M | 0.07% | 197 |
|
|
2018
Q3 | $27.6M | Sell |
1,168,868
-81,830
| -7% | -$2M | 0.05% | 143 |
|
|
2018
Q2 | $28.8M | Buy |
1,250,698
+1,130,790
| +943% | +$26.9M | 0.07% | 137 |
|
|
2018
Q1 | $2.94M | Sell |
119,908
-2,173,202
| -95% | -$57.1M | 0.01% | 566 |
|
|
2017
Q4 | $61.5M | Buy |
2,293,110
+16,572
| +0.7% | +$421K | 0.14% | 88 |
|
|
2017
Q3 | $54.8M | Sell |
2,276,538
-59,384
| -3% | -$1.34M | 0.13% | 88 |
|
|
2017
Q2 | $50.1M | Buy |
2,335,922
+479,380
| +26% | +$9.67M | 0.14% | 96 |
|
|
2017
Q1 | $31.8M | Buy |
1,856,542
+450,922
| +32% | +$7.85M | 0.1% | 133 |
|
|
2016
Q4 | $25.2M | Buy |
1,405,620
+222,386
| +19% | +$4.03M | 0.09% | 162 |
|
|
2016
Q3 | $24.6M | Sell |
1,183,234
-207,066
| -15% | -$5.13M | 0.1% | 159 |
|
|
2016
Q2 | $37.4M | Buy |
1,390,300
+83,396
| +6% | +$2.29M | 0.15% | 120 |
|
|
2016
Q1 | $35.4M | Sell |
1,306,904
-76,384
| -6% | -$2.05M | 0.15% | 114 |
|
|
2015
Q4 | $40.2M | Sell |
1,383,288
-45,850
| -3% | -$1.27M | 0.18% | 101 |
|
|
2015
Q3 | $38.8M | Sell |
1,429,138
-11,078
| -0.8% | -$314K | 0.19% | 98 |
|
|
2015
Q2 | $39.4M | Buy |
1,440,216
+64,480
| +5% | +$1.81M | 0.19% | 110 |
|
|
2015
Q1 | $36.7M | Buy |
1,375,736
+1,316,582
| +2,226% | +$30.3M | 0.19% | 113 |
|
|
2014
Q4 | $1.25M | Sell |
59,154
-4,520
| -7% | -$101K | 0.01% | 483 |
|
|
2014
Q3 | $1.52M | Buy |
63,674
+4,096
| +7% | +$94.3K | 0.02% | 474 |
|
|
2014
Q2 | $1.38M | Buy |
59,578
+17,908
| +43% | +$395K | 0.01% | 453 |
|
|
2014
Q1 | $951K | Sell |
41,670
-34,340
| -45% | -$732K | 0.01% | 476 |
|
|
2013
Q4 | $1.4M | Buy |
76,010
+4,810
| +7% | +$83.8K | 0.02% | 365 |
|
|
2013
Q3 | $1.21M | Sell |
71,200
-480
| -0.7% | -$8.07K | 0.01% | 370 |
|
|
2013
Q2 | $1.11M | Buy |
+71,680
| New | +$1.19M | 0.01% | 389 |
|
Other funds holding NVO
DAM
F
Envestnet Asset Management's NVO Position: Q1 2026 in Review
Envestnet Asset Management increased its Novo Nordisk (NVO) stake by 43% in Q1 2026, buying an estimated $56.2M and bringing the position to 3,959,430 shares worth $146M. The position accounts for 0.04% of the portfolio, ranked #413.
Envestnet Asset Management first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $607M in Q2 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Envestnet Asset Management held 3,959,430 shares of Novo Nordisk worth $146M as of Q1 2026.
- Envestnet Asset Management bought 1,185,996 Novo Nordisk shares in Q1 2026, an estimated $56.2M.
- Novo Nordisk made up 0.04% of Envestnet Asset Management's portfolio in Q1 2026, its #413 holding.
- Envestnet Asset Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's Novo Nordisk position peaked at $607M in Q2 2024.
- 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.